Cardiovascular Imaging and Plaque - Cardiovascular Update

New cardiovascular imaging approach provides a better view of dangerous plaques

Science Daily - Heart Disease

MARCH 5, 2024

Researchers have developed a new catheter-based device that combines two powerful optical techniques to image the dangerous plaques that can build up inside the arteries that supply blood to the heart.

Plaque

Plaque Cardiovascular Imaging Heart Attack Heart attacks

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

Circulation: Cardiovascular Imaging

JANUARY 11, 2024

Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Recently, it was reported that noncalcified plaque (NCP) volume was an independent predictor for cardiac events. P<0.001) than the group with low NCP plaque volume. P<0.001) than the group with low NCP plaque volume. versus 75.9%;P<0.001),

Plaque

Plaque Cardiovascular Imaging Cholesterol Circulation

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

DAIC

MAY 23, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging. milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. ,

Plaque

Plaque Coronary Artery Disease Technology Anatomy

Should You Take A Statin To Lower Your Cholesterol?

Dr. Paddy Barrett

NOVEMBER 8, 2024

The most accurate way (But not the only way) to answer this question is whether or not you have plaque in your coronary arteries. If you already have plaque, your risk of event an event goes up proportional to the amount of plaque you have 2. 2 JACC: Cardiovascular Imaging May 2015, 8 (5) 579-596; 2022;18(6).

Cholesterol

Cholesterol Plaque Heart attacks Heart Attack

Why Waiting Until Age 50 To Address Risk Factors For Heart Disease Is Too Late.

Dr. Paddy Barrett

FEBRUARY 27, 2024

The reason: They were accumulating plaque in their coronary arteries much earlier than their peers. You can’t have a heart attack if you don’t have plaque in your coronary arteries. And plaque in your coronary arteries is the result of exposure to risk factors over time. The answer: Risk Factors. The answer.

Risk Factors

Risk Factors Heart Disease Heart Attack Heart attacks

Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study

Circulation: Cardiovascular Imaging

JANUARY 11, 2024

Circulation: Cardiovascular Imaging, Ahead of Print. A decrease in the percentage of unstable core (fibro-fatty+necrotic plaque; from 14.1 [7.9–22.3] BACKGROUND:Intensive lipid-lowering therapy may induce coronary atherosclerosis regression. The global coronary PB changed from 34.6% (32.5%–36.8%) 36.8%) at entry to 30.4% (27.4%–33.4%)

Plaque

Plaque Atherosclerosis Cardiovascular Imaging Cardiovascular Disease

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging

Predictors of Rapid Coronary Plaque Progression Measured by CT: More Opportunities to Optimize Prevention

Circulation: Cardiovascular Imaging

JULY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 7 , Page e017135, July 1, 2024.

Plaque

Plaque Cardiovascular Imaging Circulation

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

FEBRUARY 13, 2024

25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. Presented at the European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials.

Coronary Artery Disease

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging

Combined Assessment of Quantitative Coronary Plaque Characteristics and Perivascular Inflammation for Better Detection of High Risk

Circulation: Cardiovascular Imaging

JANUARY 10, 2024

Circulation: Cardiovascular Imaging, Ahead of Print.

Cardiovascular Imaging

Cardiovascular Imaging Plaque Circulation

Prognostic Value of Coronary Atherosclerotic Burden, Its Plaque Components and Estimation of Coronary Flow by Coronary Computed Tomography

Circulation: Cardiovascular Imaging

MARCH 12, 2024

Circulation: Cardiovascular Imaging, Ahead of Print.

Cardiovascular Imaging

Cardiovascular Imaging Plaque Circulation

Defining the Role of Lp(a) in High-Risk Plaques: The Road to Validation of IVUS, NIRS, OCT, and CTA Approaches

Circulation: Cardiovascular Imaging

NOVEMBER 18, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 11 , Page e017613, November 1, 2024.

Cardiovascular Imaging

Cardiovascular Imaging Plaque Circulation

Cleerly Raises $106 Million in Series C Extension Funding

DAIC

DECEMBER 5, 2024

This funding will allow us to expand our commercial reach, which is especially germane following our recent achievements in attaining Medicare coverage and a CPT Category I code for advanced plaque analysis. Barclay continued, “Cardiovascular disease is the #1 cause of death globally and costs our country $422B annually.

Coronary Artery Disease

Coronary Artery Disease Medicare Plaque Technology

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

DAIC

FEBRUARY 23, 2024

in European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials. With Plaque Features Associated with False Positives. Derivation, Validation and Prognostic Assessment of an AI-Based Algorithm for Determination of Coronary Ischemia: The CREDENCE and PACIFIC Trial. Barcelona, Spain.

Ischemia

Ischemia Coronary Artery Disease Physiology Cardiovascular Imaging

AI Clearances Surge, Cardio AI Share Declines

CardiacWire

MAY 18, 2024

Cardiovascular AI maintains a (distant) second largest share of FDA-cleared AI products, with 10% of total clearances (90), well below radiology’s 76% share (671). Cardiovascular AI actually makes up a larger 17.4% FFRCT, coronary plaque, etc). in 2020-2022, and 13.5% since the start of 2023.

Cardiovascular Imaging

Cardiovascular Imaging Plaque Innovation Ablation

Tissue characterisation and primary percutaneous coronary intervention guidance using intravascular ultrasound: rationale and design of the SPECTRUM study

Open Heart

APRIL 18, 2022

Baseline tissue characterisation includes the morphological description of culprit lesion plaque characteristics and thrombus as assessed with HD-IVUS. Study findings will be submitted to international peer-reviewed journals in the field of cardiovascular imaging and interventions and will be presented at international scientific meetings.

Ultrasound

Ultrasound Myocardial Infarction Cardiovascular Imaging Plaque

Cardiology AI Clearances Growing, Diversifying

CardiacWire

AUGUST 9, 2024

However, cardiovascular AI actually made up a larger 18% share of total H1 2024 clearances (19 devices) if you also count cardiovascular imaging AI products that the FDA technically categorized within its “Radiology” segment (e.g.

Innovation

Innovation TAVR Cardiovascular Imaging Plaque

What To Do If You Have An Early Family History Of Heart Disease

Dr. Paddy Barrett

JUNE 21, 2024

Therefore, if someone presents with an event earlier than this age, they likely have been building up plaque for a considerable period prior to this. A CT CAC score of 0 means a person has no calcified coronary artery plaque and also means their risk of a heart attack over the next ten years is probably less than 2%. Genes (Basel).

Heart Disease

Heart Disease Heart Attack Heart attacks Coronary Artery Disease

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016178, February 1, 2024. BACKGROUND:It is not known whether there is a sex difference in the association between perivascular inflammation and plaque vulnerability. All images were analyzed at a core laboratory. plaques per patient). versus 46.9%,P=0.002

Plaque

Plaque Coronary Artery Disease Laboratory Cardiovascular Imaging

Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. 18F-flourodeoxyglucose resting amygdalar uptake, an imaging biomarker of stress-related neural activity, coronary inflammation (fat attenuation index), and high-risk plaque characteristics were assessed by coronary computed tomography angiography.

Atherosclerosis

Atherosclerosis Plaque Coronary Artery Disease Biomarkers

New cardiovascular imaging approach provides a better view of dangerous plaques

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

Should You Take A Statin To Lower Your Cholesterol?

Why Waiting Until Age 50 To Address Risk Factors For Heart Disease Is Too Late.

Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

Predictors of Rapid Coronary Plaque Progression Measured by CT: More Opportunities to Optimize Prevention

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Combined Assessment of Quantitative Coronary Plaque Characteristics and Perivascular Inflammation for Better Detection of High Risk

Prognostic Value of Coronary Atherosclerotic Burden, Its Plaque Components and Estimation of Coronary Flow by Coronary Computed Tomography

Defining the Role of Lp(a) in High-Risk Plaques: The Road to Validation of IVUS, NIRS, OCT, and CTA Approaches

Cleerly Raises $106 Million in Series C Extension Funding

Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve

AI Clearances Surge, Cardio AI Share Declines

Tissue characterisation and primary percutaneous coronary intervention guidance using intravascular ultrasound: rationale and design of the SPECTRUM study

Cardiology AI Clearances Growing, Diversifying

What To Do If You Have An Early Family History Of Heart Disease

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity

Stay Connected